# Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)

> **NCT01333072** · PHASE4 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 80 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT01333072
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333072, "Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01333072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*